Skip to content

On this page

Unloxcyt

cosibelimab-ipdl

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Unloxcyt

Proper name

cosibelimab-ipdl

Licence type

351(a)

BLA number

761297

Applicant

Sun Pharmaceutical Industries, Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
300MG/5ML (60MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	December 13, 2024

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity